Breathing treatment tested to halt dangerous allergy attacks
NCT ID NCT07038746
Summary
This early-stage study is testing whether inhaling epinephrine (adrenaline) can quickly stop serious allergic reactions that happen during allergy testing or treatment. The research will involve up to 100 people aged 12 and older who experience moderate to severe reactions during planned allergy procedures. Doctors will measure how fast the inhaled treatment resolves allergy symptoms compared to standard care.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HYPERSENSITIVITY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Kokua Pharma Inc.
RECRUITINGRichmond, British Columbia, V7C 5L9, Canada
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Conditions
Explore the condition pages connected to this study.